Vir Biotechnology, Inc. (VIR) stock
VIRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 11/3030% below fair value
$9.25−0.33 (-3.44%)
Close on Nov 17, 2026Market cap $1.57BP/E –Yield –
Vir Biotechnology market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Vir Biotechnology's market cap was $2.22B on Nov 11, 2026, against $892.53M a year earlier. Over the last 5 years it ranged from $682.03M to $5.48B, with a median of $1.42B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $2.22B | +165.0% |
| 2025 | Dec 31, 2025 | $838.31M | -16.5% |
| 2024 | Dec 31, 2024 | $1.00B | -25.8% |
| 2023 | Dec 29, 2023 | $1.35B | -59.8% |
| 2022 | Dec 30, 2022 | $3.37B | -38.5% |
| 2021 | Dec 31, 2021 | $5.48B | +61.1% |
| 2020 | Dec 31, 2020 | $3.40B | +2205.9% |
| 2019 | Dec 31, 2019 | $147.48M | – |
See a number that looks wrong?